Clinical trials · Buffalo, NY
Metastatic Triple-Negative Breast Carcinoma clinical trials in Buffalo
We’re tracking 4 recruiting metastatic triple-negative breast carcinoma studies with a site in or near Buffalo — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Buffalo
- NCT06434064RecruitingPhase 2
Tamoxifen and chemotherapy for triple negative breast cancer
This trial tests a combination of tamoxifen (a hormonal therapy) and pegylated liposomal doxorubicin (a type of chemotherapy) for people with triple negative breast cancer that has spread or cannot be removed by surgery. It aims to see if this combination can help people whose cancer has not responded to at least two prior treatments.
Buffalo, New YorkAges 18 years+ - NCT05741164RecruitingPhase 2
Propranolol plus pembrolizumab for hard-to-treat breast cancer
This Phase 2 trial studies whether adding propranolol to pembrolizumab can “re-sensitize” tumors and slow cancer in triple-negative breast cancer that no longer responds to checkpoint immunotherapy. It may help some people whose cancer has grown despite prior pembrolizumab and chemotherapy.
Buffalo, New YorkAges 18 years+ - NCT05812807RecruitingPhase 3
Pembrolizumab versus monitoring after triple-negative breast cancer response
This trial checks whether giving pembrolizumab (an immunotherapy) after surgery helps people with triple-negative breast cancer reduce the chance of the cancer coming back, compared with close monitoring only. It’s for patients who had no remaining invasive cancer after neoadjuvant chemotherapy plus pembrolizumab.
Buffalo, New YorkAges 18 years+ - NCT04348747RecruitingPhase 2
Vaccine plus pembrolizumab for breast cancer in the brain
This trial studies whether a personalized immune-cell vaccine (dendritic cell vaccine) combined with pembrolizumab can help control brain metastases from certain types of breast cancer. It may help your immune system better recognize and attack cancer cells in the brain.
Buffalo, New YorkAges 18 years+
Hear when a new Metastatic Triple-Negative Breast Carcinoma trial opens near Buffalo, NY
We’ll email you when one opens near Buffalo, NY — at most once a week, no account needed, unsubscribe anytime.
Metastatic Triple-Negative Breast Carcinoma trials in other cities
Where these studies are running near Buffalo
Institutions with a site for the recruiting metastatic triple-negative breast carcinoma studies listed above.
- Roswell Park Cancer Institute · 4 studies
What taking part in a metastatic triple-negative breast carcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting metastatic triple-negative breast carcinoma studies in New York.
Common questions
- Are there metastatic triple-negative breast carcinoma clinical trials near Buffalo?
- Yes. We're currently tracking 4 recruiting metastatic triple-negative breast carcinoma studies with a site near Buffalo, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a metastatic triple-negative breast carcinoma study near Buffalo?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Buffalo to take part?
- Not necessarily. These studies have a site near Buffalo, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a metastatic triple-negative breast carcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New metastatic triple-negative breast carcinoma studies open near Buffalo regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.